Genome Sequencing of Gastric Cancer Treated with Protopanaxadiol Derivatives
This project treated human gastric cancer AGS cells with protopanaxadiol derivatives and performed transcriptome sequencing. The research aims to screen differentially expressed genes induced by compound administration, systematically elucidate the molecular mechanisms underlying the anti-gastric cancer activity of protopanaxadiol derivatives, and identify key signaling pathways and core target genes involved in tumor suppression.